Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Arcus Biosciences Inc RCUS

Healthcare Biotechnology
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical... see more

Recent & Breaking News (NYSE:RCUS)

Surface Oncology Reports Financial Results and Corporate Highlights for First Quarter 2020

GlobeNewswire May 12, 2020

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire May 11, 2020

Arcus Biosciences Announces First Quarter 2020 Financial Results and Corporate Updates

Business Wire May 5, 2020

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire April 9, 2020

Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Candidate SRF617

GlobeNewswire March 17, 2020

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire March 11, 2020

Surface Oncology Reports Financial Results and Corporate Highlights for Fourth Quarter and Full Year 2019

GlobeNewswire March 10, 2020

Arcus Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Corporate Updates

Business Wire March 5, 2020

Arcus Biosciences and Taiho Pharmaceutical Co., Ltd. Jointly Announce Taiho's Exercise of Its Option for an Exclusive License to Zimberelimab (AB122) for Its Territories in Japan and Other Asian Countries

Business Wire February 26, 2020

Arcus Biosciences to Present at the 9th Annual SVB Leerink Global Healthcare Conference

Business Wire February 12, 2020

Arcus Biosciences, in Collaboration with Genentech, Announces Two Randomized Clinical Studies to Advance AB928, a Dual Adenosine Receptor Antagonist, into Novel Combinations for Colorectal and Pancreatic Cancers

Business Wire December 18, 2019

Arcus Biosciences Appoints Patrick Machado, J.D., to its Board of Directors

Business Wire December 12, 2019

Arcus Biosciences Announces Third Quarter 2019 Financial Results and Recent Corporate Updates

Business Wire November 5, 2019

Arcus Biosciences Appoints Internationally Distinguished Physician-Scientist, Antoni Ribas, M.D., Ph.D., to Board of Directors

Business Wire October 28, 2019

Arcus Biosciences to Present Updated Data from the Phase 1 Safety Dose-Escalation Portion of the AB928 Combination Trials at the European Society for Medical Oncology (ESMO) Meeting

Business Wire September 23, 2019

Arcus Biosciences to Present at the 2019 Cantor Global Healthcare Conference

Business Wire September 19, 2019

Arcus Biosciences to Present at Upcoming Investor Conferences

Business Wire August 21, 2019

Arcus Biosciences Announces Second Quarter 2019 Financial Results and Recent Corporate Updates

Business Wire August 6, 2019

Arcus Biosciences to Present at Upcoming Investor Conferences

Business Wire July 29, 2019

Arcus Biosciences Appoints Global Immuno-Oncology Commercial Leader, Eric Hoefer as Chief Commercial Officer

Business Wire June 24, 2019